Alterola Biotech, Inc.
ABTI
$0.0013
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 7.91% | -233.39% | 124.41% | -392.84% | 8.75% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -164.02% | 437.67% | -179.72% | 195.88% | -118.74% |
| Change in Net Operating Assets | -143.58% | 129.75% | -165.72% | 3,859.34% | -85.30% |
| Cash from Operations | -315.35% | -181.52% | 93.74% | -131.29% | -263.58% |
| Capital Expenditure | -- | -- | -- | -- | 200.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -200.00% | -- |
| Cash from Investing | -- | -- | -- | -117.34% | 220.97% |
| Total Debt Issued | 15.00% | 73.94% | 36.38% | 71.75% | -- |
| Total Debt Repaid | -- | -- | -- | -- | 200.00% |
| Issuance of Common Stock | -100.00% | -99.55% | -93.84% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 139.58% | -- | -- | -- | -- |
| Cash from Financing | -56.67% | 414.78% | -85.23% | 963.98% | 396.36% |
| Foreign Exchange rate Adjustments | -2,538.10% | 96.02% | -988.66% | -105.88% | 312.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -188.74% | 711,500.00% | 101.54% | 76.28% | -198.92% |